Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenoldopam and Ketanserin for Kidney Protection in Cardiac Surgery
NCT00557219Phase 3Terminated
- Sponsor
- Medical University of Gdańsk
- Start
- Apr 2008
- Primary completion
- Apr 2015
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fenoldopam, ketanserin in acute kidney injury (AKI), sponsored by Medical University of Gdańsk. Started Apr 2008; status: terminated.
02
Drugs
fenoldopamketanserin
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT00557219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00557219.